Mitsubishi Chemical Group (TSE:4188) Risk Assessment

View and export this data going back to 2005. Start your Free Trial

What is Mitsubishi Chemical Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Mitsubishi Chemical Group is: High Risk: High uncertainty with risk-return tradeoff.

Competitive Comparison of Mitsubishi Chemical Group's Risk Assessment

For the Specialty Chemicals subindustry, Mitsubishi Chemical Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mitsubishi Chemical Group's Risk Assessment Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Mitsubishi Chemical Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Mitsubishi Chemical Group's Risk Assessment falls into.

Mitsubishi Chemical Group (TSE:4188) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Mitsubishi Chemical Group Risk Assessment Related Terms

Thank you for viewing the detailed overview of Mitsubishi Chemical Group's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Mitsubishi Chemical Group (TSE:4188) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Mitsubishi Chemical Group Corp (TSE:4188) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

MTLHY:USA MTLHF:USA M3C:Germany

Address

1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-8251

Website

https://www.mcgc.com

Mitsubishi Chemical Group Corp is a holdings company, which manufactures and sells chemicals, plastics, and pharmaceuticals. It organizes itself into three segments based on product. The Industrial Materials segment, which generates the majority of revenue, sells chemicals and polymers, including industrial gases, petrochemicals, thermoplastics, polyethylene, and polypropylene. The Performance Products segment sells electronics and designed materials, including LED lighting and equipment, specialty chemicals, polyester and industrial films, and fibers. The Health Care segment sells pharmaceuticals to treat autoimmune diseases, diabetes and kidney diseases, central nervous system treatments, and vaccines. The majority of revenue comes from Japan.

Mitsubishi Chemical Group (TSE:4188) Headlines

No Headlines